During the past decade, Beacon Medical Group Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Medical Group Clinical Research" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Rigel Pharmaceuticals" with 3 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Medical Group Clinical Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Medical Group Clinical Research" are "Heart Failure" (3 trials), "Rheumatoid Arthritis" (3 trials), "Depressive Disorder, Major" (2 trials), "Atrial Fibrillation" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Beacon Medical Group Clinical Research" in a lesser frequency.

Most popular intervention types in "Beacon Medical Group Clinical Research" are "Drug" (11 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Empagliflozin" (2 trials), "Fostamatinib disodium (R935788)" (2 trials), "Amivantamab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Medical Group Clinical Research" are 15 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Beacon Medical Group Clinical Research". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Beacon Medical Group Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Medical Group Clinical Research, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Beacon Medical Group Clinical Research has several departments that took part in Clinical trials: "Beacon Children's Hospital" - 3 trials